
Obstructive sleep apnea (OSA) is linked to adverse health effects, including an increased risk of certain cancers like melanoma. Preclinical studies show OSA's potential to promote melanoma growth through intermittent hypoxia (IH). Epidemiological studies reveal a higher melanoma occurrence in OSA patients. A new prospective study investigated OSA's impact on melanoma outcomes over five years. Untreated moderate/severe OSA correlates with a 2.5-3-fold higher risk of melanoma recurrence, metastasis, or mortality, while adherent continuous positive airway pressure (CPAP) use mitigates this risk. Further studies, including randomized trials, must confirm CPAP's benefits for melanoma patients with OSA.
Like
Save
Share